Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
Nonalcoholic fatty liver disease (NAFLD) affects approximately 30% of the population worldwide and includes nonalcoholic fatty liver, nonalcoholic steatohepatitis (NASH), and cirrhosis. Since NAFLD-associated diseases begin with steatosis, the early diagnosis of steatosis helps to prevent the progre...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Association for the Study of the Liver
2023-02-01
|
| シリーズ: | Clinical and Molecular Hepatology |
| 主題: | |
| オンライン･アクセス: | http://e-cmh.org/upload/pdf/cmh-2022-0362.pdf |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|